BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10586253)

  • 1. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells.
    Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():281-93. PubMed ID: 10586253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Absence of Myelin P
    Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
    Ann N Y Acad Sci; 1999 Oct; 883(1):281-293. PubMed ID: 29086945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice.
    Guénard V; Schweitzer B; Flechsig E; Hemmi S; Martini R; Suter U; Schachner M
    Glia; 1999 Jan; 25(2):165-78. PubMed ID: 9890631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice.
    Carenini S; Montag D; Schachner M; Martini R
    Glia; 1999 Sep; 27(3):203-12. PubMed ID: 10457367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
    Zielasek J; Toyka KV
    Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P0-deficient knockout mice as tools to understand pathomechanisms in Charcot-Marie-Tooth 1B and P0-related Déjérine-Sottas syndrome.
    Martini R
    Ann N Y Acad Sci; 1999 Sep; 883():273-80. PubMed ID: 10586252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway.
    Fischer S; Weishaupt A; Troppmair J; Martini R
    Glia; 2008 Jun; 56(8):836-43. PubMed ID: 18383340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
    Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
    J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0.
    Kobsar I; Oetke C; Kroner A; Wessig C; Crocker P; Martini R
    Mol Cell Neurosci; 2006 Apr; 31(4):685-91. PubMed ID: 16458537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis.
    Xu W; Manichella D; Jiang H; Vallat JM; Lilien J; Baron P; Scarlato G; Kamholz J; Shy ME
    J Neurosci Res; 2000 Jun; 60(6):714-24. PubMed ID: 10861783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
    Carenini S; Neuberg D; Schachner M; Suter U; Martini R
    Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants.
    Ulzheimer JC; Peles E; Levinson SR; Martini R
    Mol Cell Neurosci; 2004 Jan; 25(1):83-94. PubMed ID: 14962742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
    Plaisier E; Mougenot B; Verpont MC; Jouanneau C; Archelos JJ; Martini R; Kerjaschki D; Ronco P
    J Am Soc Nephrol; 2005 Nov; 16(11):3350-6. PubMed ID: 16162811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.